ANDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)
Started Jul 2014
376 enrolled
Overactive Bladder (OAB)
Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine
Started Jun 2013
24 enrolled
Pharmacokinetics of Mirabegron and TolterodineHealthy
A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers
Started May 2012
24 enrolled
Urinary Bladder, Overactive
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
Started May 2011
990 enrolled
Urinary Bladder, Overactive
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
Started Jul 2009
46 enrolled
Benign Prostatic Hyperplasia (BPH)